#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
APH_6__Ic.3002659.X01702.484_1285.404	APH_6__Ic.3002659.X01702.484_1285.404	1	0	27	462	APH_6__Ic	801	801	100.0	APH_6__Ic.l15.c4.ctg.1	1177	20.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	APH(6)-Ic;APH(6)-Ic is a transposon-encoded aminoglycoside phosphotransferase in S. enterica, P. aeruginosa and E. coli
APH_6__Id.3002660.AF024602.3155_3992.467	APH_6__Id.3002660.AF024602.3155_3992.467	1	0	0	48	APH_6__Id+	837	153	100.0	APH_6__Id+.l6.c30.ctg.1	153	3.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	APH(6)-Id is an aminoglycoside phosphotransferase encoded by plasmids, integrative conjugative elements and chromosomal genomic islands in K. pneumoniae, Salmonella spp., E. coli, Shigella flexneri, Providencia alcalifaciens, Pseudomonas spp., V. cholerae, Edwardsiella tarda, Pasteurella multocida and Aeromonas bestiarum;APH(6)-Id
APH_6__Id.3002660.AF024602.3155_3992.467	APH_6__Id.3002660.AF024602.3155_3992.467	1	0	0	48	APH_6__Id+	837	258	100.0	APH_6__Id+.l6.c30.ctg.2	258	2.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	APH(6)-Id is an aminoglycoside phosphotransferase encoded by plasmids, integrative conjugative elements and chromosomal genomic islands in K. pneumoniae, Salmonella spp., E. coli, Shigella flexneri, Providencia alcalifaciens, Pseudomonas spp., V. cholerae, Edwardsiella tarda, Pasteurella multocida and Aeromonas bestiarum;APH(6)-Id
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	356	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1000	19.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	269	271	ACG	18;18;16	A;C;G	18;18;16	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	264	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	111	30.0	0	.	n	.	0	G906T	SNP	906	906	G	14	14	T	8	T	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	264	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	111	30.0	0	.	n	.	0	G908A	SNP	908	908	G	16	16	A	10	A	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	264	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	111	30.0	0	.	n	.	0	A918T	SNP	918	918	A	26	26	T	15	T	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	264	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	111	30.0	0	.	n	.	0	A943G	SNP	943	943	A	51	51	G	58	G	55	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	264	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c17.ctg.1	111	30.0	0	.	n	.	0	G991T	SNP	991	991	G	99	99	T	34	T	34	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1542	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1608	50.2	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1422	1424	AGC	38;39;38	A,G;G;C	28,10;39;38	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1542	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1608	50.2	1	SNP	p	R234F	1	.	.	700	702	TTC	897	899	TTC	87;85;83	T;T;C	87;84;81	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1542	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1608	50.2	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1197	1199	CGT	63;66;68	C;G;T	62;66;68	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1542	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1608	50.2	0	HET	.	.	.	C255T	.	255	255	C	452	452	C	58	C,T	30,28	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	1542	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1608	50.2	0	HET	.	.	.	T999C	.	999	999	T	1196	1196	T	63	T,C	40,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	618	Escherichia_coli_mutant_1	1359	1359	99.78	Escherichia_coli_mutant_1.l15.c4.ctg.1	1693	19.3	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1533	1535	AAA	11;11;11	A;A;A	11;11;11	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	652	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c17.ctg.1	1645	21.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1214	1216	GAA	19;19;19	G;A;A	19;19;19	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	180	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	760	12.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	103	G	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	104	C	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	98	C	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	100	T	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	122	C	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	100	C	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	102	A	102	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	98	A	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	96	A	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	87	T	86	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	87	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	79	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	78	A	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	68	G	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	64	C	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	65	T	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	89	G	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	92	G	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	88	T	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	126	T	125	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	123	G	123	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	106	C	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	98	A,G	96,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	46	C	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	44	C	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	3	G	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	17	C	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	44	T	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	52	G	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	48	TAAA,TAA	32,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	697	76.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	111	C	111	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	C990G	SNP	990	990	C	38	38	G	8	G	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	T1002A	SNP	1002	1002	T	50	50	A	12	A	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	A1004G	SNP	1004	1004	A	52	52	G	12	G	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	C1011T	SNP	1011	1011	C	59	59	T	14	T	14	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	C1023A	SNP	1023	1023	C	71	71	A	21	A	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	T1024A	SNP	1024	1024	T	72	72	A	22	A	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	89	89	G	30	G	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.78	Pasteurella_multocida_16S.l15.c30.ctg.3	141	14.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	90	90	T	30	T	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	114	94.74	Pasteurella_multocida_16S.l15.c30.ctg.4	117	66.7	0	.	n	.	0	G375A	SNP	375	375	G	75	75	A	53	A	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	114	94.74	Pasteurella_multocida_16S.l15.c30.ctg.4	117	66.7	0	.	n	.	0	G383C	SNP	383	383	G	83	83	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	114	94.74	Pasteurella_multocida_16S.l15.c30.ctg.4	117	66.7	0	.	n	.	0	G385C	SNP	385	385	G	85	85	C	23	C	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	114	94.74	Pasteurella_multocida_16S.l15.c30.ctg.4	117	66.7	0	.	n	.	0	C388G	SNP	388	388	C	88	88	G	16	G	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	114	94.74	Pasteurella_multocida_16S.l15.c30.ctg.4	117	66.7	0	.	n	.	0	C394T	SNP	394	394	C	94	94	T	7	T	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	114	94.74	Pasteurella_multocida_16S.l15.c30.ctg.4	117	66.7	0	.	n	.	0	A411T	SNP	411	411	A	111	111	T	1	T	1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	C990G	SNP	990	990	C	38	38	G	3	G	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	T1002A	SNP	1002	1002	T	50	50	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	A1003C	SNP	1003	1003	A	51	51	C	4	C	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	G1008C	SNP	1008	1008	G	56	56	C	4	C	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	C1011T	SNP	1011	1011	C	59	59	T	4	T	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	T1012C	SNP	1012	1012	T	60	60	C	5	C	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	C1023A	SNP	1023	1023	C	70	70	A	8	A	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	.1025G	INS	1025	1025	T	73	73	G	12	G	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	T1041G	SNP	1041	1041	T	89	89	G	18	G	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2014	Pasteurella_multocida_16S	1551	141	90.14	Pasteurella_multocida_16S.l15.c30.ctg.6	141	8.0	0	.	n	.	0	A1042T	SNP	1042	1042	A	90	90	T	18	T	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	570	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1483	20.5	0	.	p	.	0	H2R	NONSYN	4	6	CAT	188	190	CGT	19;19;20	C;G;T	19;18;20	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	570	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1483	20.5	0	.	p	.	0	V30I	NONSYN	88	90	GTC	272	274	ATC	26;26;26	A;T;C	26;26;26	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	570	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1483	20.5	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1031	1033	GGC	23;24;24	G;G;C	23;24;24	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1938	21.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	152	154	AGC	8;8;9	A;G;C	8;8;9	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1938	21.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	554	556	CTA	15;15;15	C;T;A	15;15;15	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1938	21.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1073	1075	CAA	32;33;32	C;A;A	32;33;32	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1938	21.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1172	1174	GGT	33;34;35	G;G;T	33;34;35	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1938	21.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1742	1744	GTT	23;22;21	G;T;T	23;22;21	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	434	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1398	16.3	0	.	p	.	0	A125E	NONSYN	373	375	GCA	521	523	GAA	18;18;18	G;A;A	18;18;18	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	434	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1398	16.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	701	703	ACC	11;11;11	A;C;C	11;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	434	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1398	16.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	821	823	ACT	9;9;7	A;C;T	9;9;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	434	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1398	16.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1211	1213	ATC	8;7;7	A;T;C	8;7;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	526	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1376	20.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	126	TEM_1+	858	451	98.89	TEM_1+.l15.c30.ctg.1	454	7.2	0	.	p	.	0	H162R	NONSYN	484	486	CAT	99	101	CGT	3;3;3	C;G;T	3;3;3	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	126	TEM_1+	858	451	98.89	TEM_1+.l15.c30.ctg.1	454	7.2	0	.	p	.	0	M261T	NONSYN	781	783	ATG	396	398	ACG	3;3;2	A;C;G	3;3;2	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	126	TEM_1+	858	154	98.05	TEM_1+.l15.c30.ctg.2	154	5.0	0	.	p	.	0	V82I	NONSYN	244	246	GTT	151	153	ATT	4;4;4	A;T;T	4;4;4	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1430	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3533	21.6	0	.	p	.	0	T85I	NONSYN	253	255	ACC	458	460	ATC	15;14;14	A;T;C	15;14;14	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1430	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3533	21.6	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2171	2173	AAG	15;16;16	A;A;G	15;16;16	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	602	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1398	22.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	229	231	GTC	6;5;5	G;T;C	6;5;5	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	602	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1398	22.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	970	972	TGC	27;30;33	T;G;C	27;30;33	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1460	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2800	27.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	177	177	T	19	T	19	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1460	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2800	27.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	483	485	GAC	23;23;26	G;A;C	23;23;26	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1460	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2800	27.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	759	761	TTA	18;17;17	T;T;A	17;17;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1460	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2800	27.3	0	.	p	.	0	D301N	NONSYN	901	903	GAT	942	944	AAT	19;23;22	A;A;T	18;23;22	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1460	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2800	27.3	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1729	1729	T	47	T	46	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1460	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2800	27.3	0	HET	.	.	.	G186A	.	186	186	G	227	227	G	27	G,A	21,6	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1460	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2800	27.3	0	HET	.	.	.	T231C	.	231	231	T	272	272	T	36	T,C	30,6	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	292	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1017	15.3	1	SNP	p	R45C	0	.	.	133	135	CGC	321	323	CGC	23;23;23	C,T;G;C,T	22,1;23;22,1	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	284	acrS	663	663	98.64	acrS.l6.c4.ctg.1	906	16.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	181	183	TTC	12;12;13	T;T;C	12;12;13	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	284	acrS	663	663	98.64	acrS.l6.c4.ctg.1	906	16.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	445	447	GGG	18;18;19	G;G;G	18;18;19	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	390	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1106	18.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	591	593	CTT	28;28;29	C;T;T	28;28;29	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1580	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3018	27.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2044	2046	GCA	37;37;38	G,A;C;A	36,1;37;38	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1580	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3018	27.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2305	2307	ACC	21;21;21	A;C;C	18;21;21	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1580	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3018	27.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2614	2616	GCC	27;28;29	G;C;C	27;27;29	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	848	arnA_1	1983	1545	98.71	arnA_1.l15.c17.ctg.1	1670	22.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	10	12	GTT	12;13;14	G;T;T	12;13;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	848	arnA_1	1983	1545	98.71	arnA_1.l15.c17.ctg.1	1670	22.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	160	162	CAC	17;16;15	C;A;C	17;16;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	848	arnA_1	1983	1545	98.71	arnA_1.l15.c17.ctg.1	1670	22.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	445	447	ATG	39;39;39	A;T;G	38;38;37	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	848	arnA_1	1983	1545	98.71	arnA_1.l15.c17.ctg.1	1670	22.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1441	1443	CGC	21;19;20	C;G;C	21;18;19	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	848	arnA_1	1983	246	95.93	arnA_1.l15.c17.ctg.2	246	10.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	32	34	GAG	3;3;3	G;A;G	2;2;2	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	848	arnA_1	1983	246	95.93	arnA_1.l15.c17.ctg.2	246	10.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	68	70	TGC	4;6;5	T;G;C	4;6;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	324	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1185	14.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	836	838	ACC	12;12;12	A;C;C	12;12;12	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	324	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1185	14.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	848	850	TCG	13;13;13	T;C;G	13;13;13	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	358	baeR	723	723	97.79	baeR.l15.c4.ctg.1	982	19.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	584	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1754	17.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1280	1282	AAA	7;7;6	A;A;A	7;7;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	584	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1754	17.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1292	1294	GAG	6;6;6	G;A;G	6;6;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	584	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1754	17.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1298	1300	CAC	8;8;9	C;A;C	8;8;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	584	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1754	17.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1352	1354	GAG	18;18;17	G;A;G	17;18;17	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	670	cpxA	1374	1374	98.91	cpxA.l6.c30.ctg.1	1812	19.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	384	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1026	19.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	532	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1356	20.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	663	665	ACT	19;18;18	A;C;T	18;18;18	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	518	emrA	1173	1173	98.29	emrA.l15.c4.ctg.2	1204	21.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	670	672	GTC	24;24;24	G;T;C	23;24;24	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	860	emrB	1539	1539	99.74	emrB.l6.c30.ctg.1	1951	23.3	0	.	p	.	0	E197K	NONSYN	589	591	GAA	778	780	AAA	21;20;20	A;A;A	21;20;20	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	536	emrD	1191	1093	98.35	emrD.l15.c4.ctg.1	1279	20.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	811	813	AGC	23;25;28	A;G;C	23;25;28	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	536	emrD	1191	94	98.94	emrD.l15.c4.ctg.2	274	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	20	emrE_1	333	77	96.1	emrE_1.l15.c4.ctg.2	77	7.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	492	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1482	17.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	747	749	AGG	11;12;12	A;G;G	11;12;12	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	492	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1482	17.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1137	1139	GAC	10;11;11	G;A;C	10;11;11	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	304	emrR	531	531	100.0	emrR.l15.c4.ctg.1	911	17.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	614	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	1984	16.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	292	evgA	615	615	99.19	evgA.l6.c17.ctg.1	835	17.5	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	249	251	CTG	22;25;25	C;T;G	22;25;25	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	274	276	ATA	10;10;8	A;T;A	10;10;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	286	288	GTA	4;4;6	G;T;A	4;4;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	439	441	ACG	21;19;20	A;C;G	21;19;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	502	504	GAA	11;12;13	G;A;A	10;12;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	541	543	GCT	21;21;22	G;C;T	21;21;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	559	561	GAT	20;20;20	G;A;T	20;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	646	648	TCA	14;15;14	T;C;A	13;14;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	775	777	CAG	8;8;9	C;A;G	8;8;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	913	915	GTT	16;15;15	G;T;T	16;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	1062	97.27	evgS.l15.c30.ctg.1	1224	15.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1069	1071	GAT	8;8;8	G;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	196	198	AAA	15;15;15	A;A;A	15;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	931	933	CAT	11;12;12	C;A;T	11;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	985	987	CAT	13;12;12	C;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1003	1005	AGA	8;8;8	A;G;A	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1018	1020	AAT	8;8;8	A;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1165	1167	TCC	10;15;17	T;C;C	10;15;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1330	1332	ATT	17;17;17	A;T;T	17;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1351	1353	GAT	26;27;27	G;A;T	26;27;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1465	1467	GTT	15;15;15	G,A;T;T	14,1;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1348	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2708	19.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1750	1752	CAC	15;15;13	C;A;C	15;15;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	462	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1205	20.4	1	SNP	p	P64L	0	.	.	190	192	CCA	364	366	CCA	28;29;29	C;C;A	28;29;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	462	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1205	20.4	1	SNP	p	P64H	0	.	.	190	192	CCA	364	366	CCA	28;29;29	C;C;A	28;29;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	462	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1205	20.4	1	SNP	p	P64R	0	.	.	190	192	CCA	364	366	CCA	28;29;29	C;C;A	28;29;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	462	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1205	20.4	1	SNP	p	P64A	0	.	.	190	192	CCA	364	366	CCA	28;29;29	C;C;A	28;29;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	462	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1205	20.4	1	SNP	p	P64S	0	.	.	190	192	CCA	364	366	CCA	28;29;29	C;C;A	28;29;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	226	gadE	528	528	100.0	gadE.l15.c4.ctg.1	927	13.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	84	gadW	729	122	97.54	gadW.l15.c17.ctg.1	123	15.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	338	gadX	825	825	97.94	gadX.l6.c17.ctg.1	1097	16.4	0	.	p	.	0	F53L	NONSYN	157	159	TTC	309	311	TTA	11;12;12	T;T;A	11;12;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	338	gadX	825	825	97.94	gadX.l6.c17.ctg.1	1097	16.4	0	.	p	.	0	V79I	NONSYN	235	237	GTT	387	389	ATT	15;15;15	A;T;T	15;15;15	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	338	gadX	825	825	97.94	gadX.l6.c17.ctg.1	1097	16.4	0	.	p	.	0	R246G	NONSYN	736	738	AGA	888	890	GGA	20;20;20	G;G;A	20;20;20	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	338	gadX	825	825	97.94	gadX.l6.c17.ctg.1	1097	16.4	0	.	p	.	0	S248P	NONSYN	742	744	TCG	894	896	CCG	19;19;19	C;C;G	19;19;19	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2232	2234	GAA	25;27;28	G;A;A	25;27;28	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	S83L	0	.	.	247	249	TCG	447	449	TCG	39;39;39	T;C;G	39;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	S83I	0	.	.	247	249	TCG	447	449	TCG	39;39;39	T;C;G	39;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	S83W	0	.	.	247	249	TCG	447	449	TCG	39;39;39	T;C;G	39;39;39	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	D87H	0	.	.	259	261	GAC	459	461	GAC	28;28;28	G;A;C	28;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	D87N	0	.	.	259	261	GAC	459	461	GAC	28;28;28	G;A;C	28;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	D87G	0	.	.	259	261	GAC	459	461	GAC	28;28;28	G;A;C	28;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	459	461	GAC	28;28;28	G;A;C	28;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1604	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3043	28.0	1	SNP	p	D87V	0	.	.	259	261	GAC	459	461	GAC	28;28;28	G;A;C	28;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1082	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2829	20.3	1	SNP	p	R136I	0	.	.	406	408	CGC	578	580	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1082	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2829	20.3	1	SNP	p	R136L	0	.	.	406	408	CGC	578	580	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1082	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2829	20.3	1	SNP	p	R136E	0	.	.	406	408	CGC	578	580	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1082	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2829	20.3	1	SNP	p	R136S	0	.	.	406	408	CGC	578	580	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1082	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2829	20.3	1	SNP	p	R136C	0	.	.	406	408	CGC	578	580	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1082	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2829	20.3	1	SNP	p	R136H	0	.	.	406	408	CGC	578	580	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1082	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2829	20.3	1	SNP	p	R136G	0	.	.	406	408	CGC	578	580	CGC	16;16;16	C;G;C	16;16;16	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	308	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	954	17.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	367	369	CCG	19;18;15	C;C;G	19;18;15	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	308	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	954	17.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	520	522	GCC	24;23;22	G;C;C	24;23;22	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	500	leuO	945	945	99.26	leuO.l15.c17.ctg.1	1326	19.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	182	184	TCA	18;18;18	T;C;A	18;18;18	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	236	marA	384	384	99.74	marA.l15.c4.ctg.1	717	17.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	505	507	AGC	10;9;8	A;G;C	10;9;8	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	607	609	CAT	1;1;1	C;A;T	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	V45E	0	.	.	133	135	GTG	331	333	GTG	21;20;21	G;T;G	21;19;21	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	I49S	0	.	.	145	147	ATC	343	345	ATC	22;22;22	A;T;C	22;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	A70T	0	.	.	208	210	GCA	406	408	GCA	13;13;13	G;C;A	12;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	R73C	0	.	.	217	219	CGT	415	417	CGT	12;12;12	C;G;T	12;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	R73S	0	.	.	217	219	CGT	415	417	CGT	12;12;12	C;G;T	12;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	R77C	0	.	.	229	231	CGC	427	429	CGC	7;6;6	C;G;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	R77L	0	.	.	229	231	CGC	427	429	CGC	7;6;6	C;G;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	L78M	0	.	.	232	234	CTG	430	432	CTG	6;5;5	C;T;G	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	R94H	0	.	.	280	282	CGC	478	480	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	R94S	0	.	.	280	282	CGC	478	480	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	130	marR	435	416	97.6	marR.l15.c30.ctg.1	614	10.7	1	SNP	p	V96E	0	.	.	286	288	GTA	484	486	GTA	8;8;9	G;T;A	8;8;9	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	89	91	ATC	6;6;6	A;T;C	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	107	109	GCC	3;3;4	G;C;C	3;3;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	110	112	GTG	4;4;4	G;T;G	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	137	139	GAT	5;6;6	G;A;T	5;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	158	160	ACC	5;5;5	A;C;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	185	187	TTA	3;3;3	T;T;A	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	326	328	CAG	27;27;27	C;A;G	27;27;27	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	365	367	GCC	16;16;15	G;C;C	15;15;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	470	472	GCG	29;29;28	G;C;G	29;28;27	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	674	676	GTT	8;9;10	G;T;T	8;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	410	mdfA	1233	1213	97.03	mdfA.l15.c4.ctg.1	1405	15.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	836	836	C	14	C	14	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	488	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1614	16.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	217	217	G	15	G	15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	488	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1614	16.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	274	276	CAG	9;10;11	C;A;G	9;10;11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	488	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1614	16.2	0	.	p	.	0	T83I	NONSYN	247	249	ACC	424	426	ATC	7;6;5	A;T;C	7;6;5	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	488	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1614	16.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	472	474	ATG	8;10;10	A;T;G	8;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	488	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1614	16.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	565	567	ACC	18;17;16	A;C;C	18;17;16	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	488	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1614	16.2	0	.	p	.	0	P257T	NONSYN	769	771	CCG	946	948	ACG	15;15;16	A;C;G	15;15;16	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1540	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3471	23.6	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1934	1936	ACC	34;33;34	A;C;C	34;33;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1540	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3471	23.6	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2327	2329	CAA	16;16;17	C;A;A,G	15;15;16,1	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1540	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3471	23.6	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2495	2497	ATT	22;21;22	A;T;T	22;21;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1540	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3471	23.6	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2579	2581	GTT	22;22;24	G;T;T	22;22;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1540	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3471	23.6	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2687	2689	GAG	13;12;12	G;A;G	13;12;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1540	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3471	23.6	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2915	2917	ATG	16;16;15	A;T;G	16;16;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1540	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3471	23.6	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3050	3052	GAT	15;15;15	G;A;T	14;15;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1426	mdtC	3078	3021	98.64	mdtC.l15.c4.ctg.1	3045	24.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	81	83	ATG	13;13;13	A;T;G	12;12;12	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1426	mdtC	3078	3021	98.64	mdtC.l15.c4.ctg.1	3045	24.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	567	569	ATC	33;33;34	A;T;C	33;33;34	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1426	mdtC	3078	3021	98.64	mdtC.l15.c4.ctg.1	3045	24.0	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2883	2885	CAC	3;3;3	C;A;C	3;3;3	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1426	mdtC	3078	3021	98.64	mdtC.l15.c4.ctg.1	3045	24.0	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	2886	2888	CTC	3;3;3	C;T;C	3;3;3	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	730	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1743	22.2	0	.	p	.	0	D3E	NONSYN	7	9	GAT	134	136	GAA	15;15;15	G;A;A	15;15;15	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	730	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1743	22.2	0	.	p	.	0	T226A	NONSYN	676	678	ACG	803	805	GCG	27;29;29	G;C;G	27;29;29	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	730	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1743	22.2	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1145	1147	ATC	26;25;26	A;T;C	26;25;26	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	730	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1743	22.2	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1448	1450	TTT	27;26;23	T;T;T	27;26;23	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	674	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1511	23.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1644	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3509	24.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1073	1075	ACC	18;18;18	A;C;C	18;16;18	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1644	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3509	24.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2315	2317	GAC	28;26;28	G;A;C	28;25;28	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	576	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1311	17.9	0	.	p	.	0	V200I	NONSYN	598	600	GTC	490	492	ATC	21;20;20	A;T;C	21;20;20	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	576	mdtG	1227	135	100.0	mdtG.l15.c30.ctg.3	140	17.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	544	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1343	21.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	400	402	TGT	17;17;17	T;G;T	17;17;17	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	544	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1343	21.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	970	972	TTG	28;29;24	T;T;G	28;29;24	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	544	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1343	21.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1180	1182	ACG	12;12;12	A;C;G	12;12;12	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	548	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1576	18.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	785	787	TCC	8;8;6	T;C;C	6;8;6	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	340	mdtN	1032	1032	98.06	mdtN.l6.c4.ctg.1	1271	13.6	0	.	p	.	0	V119I	NONSYN	355	357	GTT	539	541	ATT	13;14;14	A;T;T	13;14;14	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	T33I	NONSYN	97	99	ACC	61	63	ATC	16;15;15	A;T;C	13;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	C116R	NONSYN	346	348	TGC	310	312	CGC	29;28;27	C;G;C	29;28;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	N238S	NONSYN	712	714	AAC	676	678	AGC	27;28;28	A;G;C	27;28;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	M305V	NONSYN	913	915	ATG	877	879	GTG	17;17;16	G;T;G	17;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	D326N	NONSYN	976	978	GAC	940	942	AAC	9;9;9	A;A;C	9;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	K336N	NONSYN	1006	1008	AAA	970	972	AAC	14;14;13	A;A;C,A	13;13;0,10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	985	987	GTC	18;18;18	G;T;C	18;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1015	1017	ATA	21;22;21	A;T;A	21;22;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1123	1125	TCT	12;13;13	T;C;T	12;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1510	1512	GCG	26;27;27	G;C;G	26;26;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	531	914	mdtO	2052	2016	98.07	mdtO.l6.c30.ctg.1	2218	21.7	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1723	1725	ATC	31;33;33	A;T;C	31;33;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	424	426	GCG	17;17;17	G;C;G	16;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	598	600	ACC	12;13;14	A;C;C	12;13;14	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	670	672	CGC	27;27;28	C;G;C	27;26;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	787	789	GCT	18;20;20	G;C;T	17;20;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	871	873	AAA	10;9;9	A;A;A	10;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	889	891	CGA	12;12;12	C;G;A	12;12;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1054	1056	GCC	14;14;15	G;C;C	14;14;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1066	1068	GAT	15;15;15	G;A;T	15;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	546	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1535	17.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1483	1485	GCT	7;7;7	G;C;T	7;7;7	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1850	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3791	25.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1470	1472	AAG	11;12;12	A;A;G	11;12;12	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1850	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3791	25.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2547	2549	CTG	18;17;18	C;T;G	18;17;18	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	126	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	344	13.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1098	msbA	1749	1749	98.68	msbA.l6.c30.ctg.1	2060	28.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	945	947	AAC	32;32;33	A;A;C	31;30;33	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1098	msbA	1749	1749	98.68	msbA.l6.c30.ctg.1	2060	28.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1491	1493	ATA	30;30;30	A;T;A	30;30;30	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	702	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1639	22.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1298	1300	GAT	25;24;24	G;A;T	25;24;24	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	702	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1639	22.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1301	1303	CTG	24;24;26	C;T;G	24;24;25	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	271	273	TGT	17;19;20	T;G;T	17;19;20	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	541	543	ACC	7;7;7	A;C;C	7;7;7	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	751	753	GAC	13;12;11	G;A;C	13;12;11	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	1	SNP	p	R15C	0	.	.	43	45	CGC	235	237	CGC	28;28;27	C;G;C	27;28;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	1	SNP	p	S33R	0	.	.	97	99	AGC	289	291	AGC	16;16;16	A;G;C	16;16;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	1	SNP	p	G131D	0	.	.	391	393	GGC	583	585	GGC	19;19;20	G;G;C	19;19;19	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	1	SNP	p	R203C	0	.	.	607	609	CGT	799	801	CGT	14;15;17	C;G;T	14;15;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	294	nfsA	723	723	99.03	nfsA.l6.c4.ctg.1	1139	13.6	1	SNP	p	R203L	0	.	.	607	609	CGT	799	801	CGT	14;15;17	C;G;T	14;15;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	690	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1442	25.4	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1114	1116	GAG	33;34;34	G;A;G	33;34;33	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	690	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1442	25.4	1	SNP	p	G141D	0	.	.	421	423	GGT	601	603	GGT	27;25;24	G;G;T	27;23;24	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	690	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1442	25.4	1	SNP	p	G141E	0	.	.	421	423	GGT	601	603	GGT	27;25;24	G;G;T	27;23;24	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	690	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1442	25.4	1	SNP	p	R154A	0	.	.	460	462	CGT	640	642	CGT	30;32;34	C;G;T	30;32;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	690	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1442	25.4	1	SNP	p	R154D	0	.	.	460	462	CGT	640	642	CGT	30;32;34	C;G;T	30;32;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1310	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2631	26.4	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1804	1806	GTG	35;35;35	G;T;G	35;35;35	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1310	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2631	26.4	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1831	1833	TCG	29;28;25	T;C;G	25;26;24	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1310	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2631	26.4	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2446	2448	AAC	16;16;15	A;A,G;C	16;15,1;15	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1310	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2631	26.4	1	SNP	p	A85T	0	.	.	253	255	GCG	460	462	GCG	27;27;27	G;C;G	26;27;27	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1310	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2631	26.4	1	SNP	p	D111H	0	.	.	331	333	GAT	538	540	GAT	22;22;24	G;A;T	22;22;24	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1310	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2631	26.4	1	SNP	p	S129P	0	.	.	385	387	TCC	592	594	TCC	34;34;32	T;C;C	33;34;31	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	756	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2273	17.6	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1605	1607	AAC	22;23;24	A;A;C	22;22;24	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	756	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2273	17.6	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1614	1616	GAT	26;27;26	G;A;T	25;27;26	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	724	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1764	21.6	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	793	795	CAG	21;22;22	C;A;G	21;21;22	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	724	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1764	21.6	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1267	1269	GAT	21;21;20	G;A;T	21;21;20	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	V146F	0	.	.	436	438	GTT	683	685	GTT	28;29;30	G;T;T	28;29;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1784	1786	CAG	31;33;34	C;A;G	31;33;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1784	1786	CAG	31;33;34	C;A;G	31;33;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1823	1825	CAC	38;38;37	C;A;C	37;38;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1832	1834	CGT	34;34;33	C;G;T	34;34;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1832	1834	CGT	34;34;33	C;G;T	34;34;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1838	1840	TCC	32;30;29	T;C;C	32;30;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1844	1846	CTC	25;24;24	C;T;C	25;24;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1934	1936	ACC	28;27;28	A;C;C	27;27;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1937	1939	CCT	28;32;32	C;C;T	27;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2318	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4467	27.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2306	2308	CGT	52;49;48	C;G;T	52;49;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	552	185.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	167	A	164	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	552	185.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	167	A	164	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	552	185.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	167	A	164	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	.	n	.	0	A226G	SNP	226	226	A	372	372	G	208	G	207	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	1	SNP	n	A794T	0	.	.	794	794	A	940	940	A	169	A,G	162,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	1	SNP	n	A794G	0	.	.	794	794	A	940	940	A	169	A,G	162,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	1	SNP	n	G926T	0	.	.	926	926	G	1072	1072	G	161	G	159	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	1	SNP	n	G926C	0	.	.	926	926	G	1072	1072	G	161	G	159	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	1	SNP	n	G926A	0	.	.	926	926	G	1072	1072	G	161	G	159	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	A79G	.	79	79	A	225	225	A	203	A,G	163,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	C719T	.	719	719	C	865	865	C	165	C,T	104,61	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	T273A	.	273	273	T	419	419	T	186	T,A	150,33	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	T1010C	.	1010	1010	T	1156	1156	T	128	T,C	90,38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	C183T	.	183	183	C	329	329	C	157	C,T	97,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	T90C	.	90	90	T	236	236	T	184	T,C	144,38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	A250T	.	250	250	A	396	396	A	198	A,T	160,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	G474A	.	474	474	G	620	620	G	186	G,A	144,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	A253T	.	253	253	A	399	399	A	193	A,T	156,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	C194T	.	194	194	C	340	340	C	165	C,T	122,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	G1002A	.	1002	1002	G	1148	1148	G	133	G,A	94,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	1089	99.91	rrsB+.l15.c17.ctg.2	1235	159.7	0	HET	.	.	.	G1006C	.	1006	1006	G	1152	1152	G	130	G,C	90,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	110	93.69	rrsB+.l15.c17.ctg.5	110	9.6	0	.	n	.	0	G1002A	SNP	1002	1002	G	21	21	A	19	A	13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	110	93.69	rrsB+.l15.c17.ctg.5	110	9.6	0	.	n	.	0	G1006C	SNP	1006	1006	G	25	25	C	19	C	13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	110	93.69	rrsB+.l15.c17.ctg.5	110	9.6	0	.	n	.	0	T1010C	SNP	1010	1010	T	29	29	C	19	C	13	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	110	93.69	rrsB+.l15.c17.ctg.5	110	9.6	0	.	n	.	0	A1019.	DEL	1019	1019	A	37	37	G	20	G	14	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	110	93.69	rrsB+.l15.c17.ctg.5	110	9.6	0	.	n	.	0	.1023G	INS	1023	1023	T	42	42	G	20	G	14	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	5918	rrsB+	1542	110	93.69	rrsB+.l15.c17.ctg.5	110	9.6	0	.	n	.	0	C1038T	SNP	1038	1038	C	57	57	T	11	T	10	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	250	soxR	465	465	100.0	soxR.l15.c4.ctg.1	809	16.5	1	SNP	p	R20H	0	.	.	58	60	CGC	213	215	CGC	15;15;15	C;G;C	15;15;15	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	250	soxR	465	465	100.0	soxR.l15.c4.ctg.1	809	16.5	1	SNP	p	G121D	0	.	.	361	363	GGT	516	518	GGT	24;23;22	G;G;T	24;23;22	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	182	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	699	13.9	1	SNP	p	A12S	0	.	.	34	36	GCA	218	220	GCA	17;18;19	G;C;A	17;18;19	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	0	54	APH_3____Ib+	804	312	100.0	APH_3____Ib+.l15.c30.ctg.1	312	3.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	0	54	APH_3____Ib+	804	293	100.0	APH_3____Ib+.l15.c30.ctg.2	293	3.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	4	44	sul2	816	337	100.0	sul2.l15.c30.ctg.1	337	3.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	4	44	sul2	816	170	99.41	sul2.l15.c30.ctg.2	171	1.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	256	56	tetA	1200	275	100.0	tetA.l6.c30.ctg.1	302	3.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	256	56	tetA	1200	168	100.0	tetA.l6.c30.ctg.2	168	2.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	516	30	tetR	651	164	98.78	tetR.l6.c4.ctg.1	184	1.8	0	.	p	.	0	R87K	NONSYN	259	261	AGG	149	151	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	516	30	tetR	651	164	98.78	tetR.l6.c4.ctg.1	184	1.8	0	.	p	.	0	Q88R	NONSYN	262	264	CAG	152	154	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	516	30	tetR	651	103	100.0	tetR.l6.c4.ctg.2	103	1.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	942	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2014	24.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
